News & Articles

Access SARS-CoV-2 IgG II test is a semi-quantitative assay that measures patient’s relative level of antibodies in response to a previous SARS-CoV-2 infection

LC 300 platform and SimplicityChrom software offers improved workflows, intuitive user interface and 21 CFR Part 11 compliance

The collaboration aims to secure manufacturing and testing capacity in the next phase of the pandemic

Observations of rapid recovery on chest x-rays noted and no drug-related Serious Adverse Events reported

Test adds to QIAGEN’s growing portfolio of PCR testing solutions for COVID-19 testing

QIAreach SARS-CoV-2 Antigen Test is an important step towards decentralized mass screening by processing samples in 2–15 minutes

Phase 3 part of clinical trial to enrol over 30,000 volunteers worldwide

The new IgM antibody test demonstrated 99.9% specificity with 1,400 negative samples and 100% sensitivity at >18 days post symptom onset and post positive PCR

Underscores importance of serological testing using the S1 subunit for worldwide seroprevalence and vaccine development

Discover how AFABILITY founder Dr. Alison Gray is enabling the transition from animal-derived to non-animal-derived antibodies

The combined solution aims to enable researchers to reproducibly prepare samples of all types for mass spectrometry-based proteomics

Study by University of Manchester reassures patients that it is safe to take blood pressure medication during the pandemic

Proven, scalable platform aims to increase dose yields and reduces process development time for cell and gene therapies

The hypercube algorithm aims to enable regular, cost-effective screening in multiple contexts

The company aims to meet the increased demand for approved media to maintain virus viability from sample collection to the lab

The GeneSys software now combines sample positioning and image capture on one screen, making it easier for scientists to set up and image gels and blots in fewer clicks

The TaqPath test is authorized for use with the Everlywell COVID-19 Test Home Collection Kit, which enables individuals to self-collect nasal swab specimens

Watch this on-demand webinar to learn how to perform untargeted/semi-targeted metabolomic studies to discover novel biomarkers by mass spectrometry

The test uses a convolutional neural network to classify microscopy images of single intact particles of different viruses

Availability of the new IgM blood test on the ARCHITECT and Alinity platforms is part of Abbott's effort to offer tests across the disease progression of COVID-19

Easy-to-use test, which doesn't require specialized laboratory personnel or instruments, promises flexibility to test in locations that benefit from immediate results

The CTS Rotea system aims to help researchers overcome manufacturing hurdles and bring the vast potential of cell therapies to more patients

Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein